[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Night Owl Biotech Research Group [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) on x 1171 followers Created: 2025-07-22 19:49:19 UTC $SNDX is up but off XX% since 7/16/24 Revuforj's projected sales profile (w/a 10/25 label exp) is consistent w/peers acq for $1.7-$2.2B (CTIC SRRA $KDMN $KYTH, AGIO) 1st year Niktimvo sales $ projected to be XX% more than Rezurock acq for $1.9B. SNDX owns ~1/3 of Niktimvo $XBI  XXX engagements  **Related Topics** [$xbi](/topic/$xbi) [$19b](/topic/$19b) [$kyth](/topic/$kyth) [$kdmn](/topic/$kdmn) [$22b](/topic/$22b) [$sndx](/topic/$sndx) [Post Link](https://x.com/NightOwlBiotech/status/1947745795173646782)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Night Owl Biotech Research Group @NightOwlBiotech on x 1171 followers
Created: 2025-07-22 19:49:19 UTC
$SNDX is up but off XX% since 7/16/24
Revuforj's projected sales profile (w/a 10/25 label exp) is consistent w/peers acq for $1.7-$2.2B (CTIC SRRA $KDMN $KYTH, AGIO)
1st year Niktimvo sales $ projected to be XX% more than Rezurock acq for $1.9B. SNDX owns ~1/3 of Niktimvo
$XBI
XXX engagements
/post/tweet::1947745795173646782